Answers are grounded in this paper and cite their sources.
Live and decapsulated Artemia are widely used in Litopenaeus vannamei hatcheries, yet their comparative effects on postlarval (PL) physiology remain incompletely characterized. This study evaluated four dietary treatments, 100% live instar-I Artemia nauplii (D1), 100% decapsulated Artemia (D2), 66.6% live:33.3% decapsulated (D3), and 33.3% live:66.6% decapsulated (D4), co-fed with a constant micro-particulate diet (MP), on growth, survival, heat shock protein (HSP60, HSP70, HSP90) expression, whole-body fatty acid and amino acid profiles, gut microbiota, and hepatopancreatic histology in L. vannamei PL over 60 days. At the PL-15 intermediate assessment, length differed significantly among treatments ( P = 0.040), with D1 greatest, whereas weight and survival followed the same trend without reaching significance. HSP90 was significantly elevated in D3 relative to D1 ( P = 0.0014). Whole-body DHA, EPA, and ARA were highest in D2, reflecting divergent Artemia fatty acid composition, while taurine was highest in D1. Gut alpha diversity was highest in D1, and D2 showed a community disproportionately enriched in Aeromonas - and Mycobacterium -associated taxa. Histology showed intact epithelium in D1 and the most pronounced damage in D2, with D3 and D4 intermediate. These findings indicate that 100% live Artemia , and partial substitution with live Artemia (66.6:33.3 live: decapsulated), mitigates deterioration linked to exclusive decapsulated- Artemia feeding, informing strategies for live-feed-reliant and cost-sensitive hatcheries.
No takes yet. Share an insight, caveat, or question.
Kurapati et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: